Ratings Tata Chemicals Limited NSE India S.E.

Equities

TATACHEM

INE092A01019

Market Closed - NSE India S.E. Other stock markets 07:43:49 2024-05-03 EDT			5-day change	1st Jan Change
1,091 ^INR	-0.89%		-2.78%	-1.20%

04-30	Tata Chemicals Swings to Loss in Fiscal Q4; Revenue Misses Estimates	MT
04-29	Transcript : Tata Chemicals Limited, Q4 2024 Earnings Call, Apr 29, 2024

Summary

From a short-term investment perspective, the company presents a deteriorated fundamental situation

Strengths

Historically, the company has been releasing figures that are above expectations.

Weaknesses

According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
The company's currently anticipated earnings per share (EPS) growth for the next few years is a notable weakness.
The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 23.26 times its estimated earnings per share for the ongoing year.
The company is highly valued given the cash flows generated by its activity.
The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
Revenue estimates are regularly revised downwards for the current and coming years.
For the past year, analysts have significantly revised downwards their profit estimates.
For the last four months, EPS estimates made by Standard & Poor's analysts have been revised downwards.
Most analysts agree on a negative opinion with regard to the stock. Indeed, the average consensus issues recommendations to underperform or sell.
The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
The overall consensus opinion of analysts has deteriorated sharply over the past four months.
Over the past twelve months, analysts' opinions have been revised negatively.

Ratings chart - Surperformance

Sector: Diversified Chemicals

	1st Jan change	Capi.	ESG Refinitiv
TATA CHEMICALS LIMITED	-1.20%	3.33B	-
SHIN-ETSU CHEMICAL CO., LTD.	+1.22%	78.18B	B
BASF SE	+0.59%	47.18B	A-
DUPONT DE NEMOURS, INC.	+0.96%	32.47B	C
PIDILITE INDUSTRIES LIMITED	+8.75%	18.01B	B
BRENNTAG SE	-9.28%	11.74B	B
EASTMAN CHEMICAL COMPANY	+8.55%	11.47B	A-
SYENSQO SA/NV	-2.33%	10.43B	-
ASAHI KASEI CORPORATION	+5.97%	9.98B	A-
SRF LIMITED	+3.48%	9.12B	C-

Investor Rating

Trading Rating

ESG Refinitiv

Financials

Sales growth

Earnings Growth

EBITDA / Sales

Profitability

Finances

Valuation

P/E ratio

EV / Sales

Price to Book

Price to Free Cash Flow

Yield

Momentum

1 year Revenue revision

4 months Revenue revision

7 days Revenue revision

1 year EPS revision

4 months EPS revision

Consensus

Analyst Opinion

Potential Price Target

4m Target Price Revision

4m Revision of opinion

12m Revision of opinion

Business Predictability

Analyst Coverage

Divergence of Estimates

Divergence of analysts' opinions

Divergence of Target Price

Earnings quality

Technical analysis

ST Timing

MT Timing

LT Timing

RSI

Bollinger Spread

Unusual volumes